ISMIVS Newsletter September & October, 2025 Newsletter ISMIVS

ISMIVS Newsletter September & October, 2025

Newsletter 2025 September & October
2025年9&10月简报

About Us 国际微无创医学会简介

The International Society of Minimally Invasive and Virtual Surgery (ISMIVS, previously known as International Society of Minimally Invasive and Noninvasive Medicine) was founded in July 2013 at the gala of the 1st Yangtze International Summit of Minimally Invasive and Noninvasive Medicine in Chongqing, China. ISMIVS envisions to accelerating the progress in minimally invasive and noninvasive medicine by promoting research, education, communication, and international collaboration.
国际微无创医学会（ISMIVS）是在 2013 年 7 月在中国重庆召开的第一届国际微无创医学长江高峰论坛上宣布成立的，旨在通过学术研究、教育、交流以及国际合作加快微无创医学的发展。

Become a member 注册成为会员 >

Ideas about Young ISMIVS 医路青春专访栏目

Ideas about Young ISMIVS
医路青春专访栏目

In July 2023, the Young ISMIVS Committee was formally established in order to respond to the development trend of minimally invasive and noninvasive medicine, and further consolidate the core group of young physicians.
为顺应微无创医学发展的趋势，进一步凝聚中青年微无创医学骨干的力量，推动微无创医学的发展。2023年7月，国际微无创医学会“青年委员会”（以下简称“青委会”）正式成立。
As the youth force of the new era in the field of minimally invasive and noninvasive medicine, the Young ISMIVS Committee carries the important mission of enlightening medical innovation and leading the development of this field. It will become a solid pillar to promote the breakthroughs in minimally invasive and noninvasive medicine to new heights through its unique vitality and profound deposits.
青委会作为微无创领域新时代的青春力量，承载着启迪医学创新、引领微无创技术发展的重要使命，将凭借其独特的创新活力和深厚的专业积淀，成为推动微无创领域不断突破、迈向新高峰的坚实砥柱。
In medicine, a group of passionate young physicians, who harbor the love and persistence for minimal invasiveness and non-invasiveness, keep exploring and moving forward. They are the members of the Young ISMIVS Committee, who contribute to the development of this field with their enthusiasm and wisdom.
在医学的广阔天地里，这样一群热血的青年医者，他们怀揣着对微无创医学的热爱与执着，不断探索、不断前行。他们，正是青委会的成员，他们以青春的热情与智慧，为微无创医学的发展贡献着自己的力量。
In conjunction with Da Yi Wei Ke, we are now introducing the first interview show – Ideas about Young ISMIVS. Let's get closer to this group of young doctors, listen to their stories on the path of minimally invasive and non-invasive medicine, feel their passion and persistence, and witness the bright future together.
国际微无创医学会青年委员会联合大医微课策划出品，首档人物专访节目《医路青春》正在播出。让我们走近这群青年医者，聆听他们在微无创路上的成长故事，感受他们的热情与执着，共同见证微无创医学的辉煌未来。

Ideas about Young ISMIVS with:
本期嘉宾：

Dr. Deng Yongbin
Senior HIFU Physician of Chongqing Haifu Hospital
邓勇斌
重庆海扶医院高级HIFU医师

-Standing Committee Member, Youth ISMIVS Committee
-Director, Medical Education Department, Chongqing Haifu Hospital
-Deputy Director, Research Center for Minimally Invasive Treatment of Benign Uterine Diseases (Chongqing)
-Senior Lecturer, FUS International Clinical Training Base
-国际微无创医学会青年委员会常务委员
-重庆海扶医院医教部主任
-重庆市子宫良性疾病微无创治疗研究中心副主任
-FUS国际临床培训基地高级培训师

Watch the interview:

https://youtu.be/O3RF_5tDzPg

观看本期采访：

https://mp.weixin.qq.com/s/JuNWXVX-rov0OiuQe5JdYQ

News 新闻

Parallel Session of ISMINIM 2025:
New Advances in Minimally Invasive and Non-Invasive Treatments for Uterine Fibroids
2025 微无创医学长江论坛分会场精彩速递：子宫肌瘤的微无创治疗新进展

On June 22, 2025, the parallel session of“New Advances in Minimally Invasive and Non-Invasive Treatments for Uterine Fibroids”of the 2025 Yangtze Summit of Minimally Invasive and Noninvasive Medicine & Annual Academic Conference of the Focused Ultrasound Therapy Branch of Chongqing Medical Association was rounded off.
6 月 22 日，2025 微无创医学长江论坛暨重庆市医学会聚焦超声治疗分会学术年会分论坛“子宫肌瘤的微无创治疗新进展”圆满举行。

Moderators included: Jordi Rodriguez, Department of Obstetrics and Gynecology, Mútua Terrassa University Hospital, Spain; Chen Hengxi, Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University; Oliver Cruz, Department of Obstetrics and Gynecology, Gynecologic Endoscopy and Robotics UNAM INPer México; Zhang Chun, Director of Gynecology, the Central Hospital of Wuhan.
西班牙特拉萨大学医院妇产科 Jordi Rodriguez（西班牙）、四川大学华西第二医院妇产科陈恒禧、墨西哥国立自治大学妇产科 Oliver Cruz（墨西哥）、武汉市中心医院妇科主任张淳等人担任主持
Prof. Xue Min from Third Xiangya Hospital of Central South University, explored the clinical efficacy and reproductive outcomes of HIFU therapy for uterine fibroids. She emphasized the non-invasive advantages of this approach in preserving patients' fertility and shared the latest advancements and application prospects of this technology.
中南大学湘雅三医院薛敏教授探讨了 HIFU 治疗子宫肌瘤的临床疗效及生殖预后，强调其无创优势对患者生育功能的保护作用，并分享了该技术的最新进展与应用前景。
Prof. Sharifah Halimah Jaafar from Hospital Picaso, Petaling Jaya, Malaysia, presented on how robotic-assisted myomectomy minimizes uterine damage through precise manipulation. She emphasized the clinical value and practical experience of this technique in preserving female fertility.
马来西亚八打灵再也市毕加索医院 Sharifah Halimah Jaafar 教授介绍了机器人辅助子宫肌瘤切除术中如何通过精准操作减少子宫损伤，重点分析了该技术对女性生育力保护的临床价值与实践经验。
Prof. Zhou Honggui, Dean of the School of Nursing, North Sichuan Medical College, focused on minimally invasive treatments for type II submucosal uterine fibroids. By comparing clinical data on the impact of different surgical approaches on pregnancy outcomes, he proposed recommendations for optimizing treatment strategies.
川北医学院护理学院院长周洪贵教授聚焦II型粘膜下子宫肌瘤的微无创治疗，通过临床数据对比不同术式对妊娠结局的影响，提出优化治疗策略的建议。
Prof. Alexander Mustea, Chair and Head of the Department for Gynecology and Gynecological Oncology, University Hospital Bonn, systematically outlined the technical essentials of robotic surgery for uterine fibroids. Drawing on German experience, he explored its surgical efficiency and advantages for patient recovery.
德国波恩大学医院妇科和妇科肿瘤科主任 Alexander Mustea 教授系统阐述了机器人手术在子宫肌瘤治疗中的技术要点，结合德国经验探讨其手术效率与患者康复优势。

Dr. Sandee Go from St. Luke's Medical Center in the Philippines, Prof. Chen Xiangdong from Foshan Maternity and Child Health Hospital, and Prof. Xiao Chengwei from the Second Affiliated Hospital of Bengbu Medical University engaged in a discussion session focusing on expanding the indications for minimally invasive techniques and fostering multidisciplinary collaboration, emphasizing the importance of individualized treatment decisions.
菲律宾圣卢克医疗中心 Sandee Go 教授、佛山市妇幼保健院陈向东教授和蚌埠医科大学第二附属医院肖成炜教授在讨论环节围绕微无创技术的适应症拓展与多学科协作展开对话，强调个体化治疗决策的重要性。
Dr. Chung Kuo Teng, Director of the HIFU Center of the Taipei Chung Shan Hospital, conducted a comparative analysis of the therapeutic efficacy differences between HIFU and transvaginal myomectomy for posterior uterine wall fibroids. He proposed an individualized treatment selection strategy based on anatomical characteristics.
台北中山医院海扶中心主任钟国腾教授对比分析了HIFU与经阴道肌瘤切除术治疗后壁子宫肌瘤的疗效差异，提出基于解剖特点的个体化方案选择策略。
Prof. Slabozhankina Ekaterina from Federal State Budgetary Institution “National Medical and Surgical Center named after N.I. Pirogov”of the Ministry of Health of the Russian Federation, shared insights on the large-scale application of HIFU technology in Russian medical institutions. This included the establishment of standardized procedures and long-term follow-up outcomes.
俄罗斯卫生部联邦国家预算机构“尼古拉·皮罗戈夫国家医学外科中心”Slabozhankina Ekaterina 教授分享了俄罗斯联邦医疗机构 HIFU 技术的规模化应用经验，包括标准化流程建立与长期随访结果。
Prof. Hu Lina from the Second Affiliated Hospital of Chongqing Medical University reviewed innovative advances in uterine preservation therapies, highlighting the potential of biomaterials and regenerative medicine in uterine repair.
重庆医科大学附属第二医院胡丽娜教授综述了子宫保护性治疗方法的创新进展，突出生物材料与再生医学在子宫修复中的潜力。
Prof. Deng Kaixian, Vice President of Shunde Hospital of Southern Medical University, explored treatment decision-making guided by multimodal imaging from a precision medicine perspective, advocating for the synergistic application of minimally invasive techniques to enhance therapeutic efficacy.
南方医科大学顺德医院副院长邓凯贤教授从精准医学角度探讨多模态影像引导下的治疗决策，倡导微无创技术的协同应用以提升疗效。
Dr. Xie Shanli from Guangyuan First People's Hospital, Prof. Liu Zhaohong, Director of Gynecology at the Alar Hospital of the Xinjiang Production and Construction Corps affiliated with Zhejiang University's Sir Run Run Shaw Hospital, and Prof. Fan Yang from Ningxia Hui Autonomous Region People's Hospital engaged in a discussion. Drawing on international practices, they explored the balance of technical choices under varying healthcare resource contexts and the need for standardized development of postoperative fertility assessment systems.
广元市第一人民医院谢珊莉、浙江大学附属邵逸夫医院兵团阿拉尔医院妇科主任刘照红教授和宁夏回族自治区人民医院樊杨教授在讨论中结合国际实践，探讨了不同医疗资源背景下技术选择的平衡，以及术后生育力评估体系的规范化建设需求。

Watch the playback of the Summit:

https://www.youtube.com/playlist?list=PLWbjlVbxcLm3p9sE4xg3Z8YdcvZ4xOuYj

观看会议回放：

https://live.dayiweike.com/video/huikan/1980?m=jin

New Perspective in Focused Ultrasound 聚焦超声新视角

Ultrasound-guided high-intensity focused ultrasound ablation for uterine arteriovenous fistula: a case series
超声引导下高强度聚焦超声消融治疗子宫动静脉瘘：病例系列研究

This article is to evaluate the efficacy and safety of high-intensity focused ultrasound (HIFU) ablation in the treatment of uterine arteriovenous fistula (UAVF).

本文旨在评估高强度聚焦超声（HIFU）消融术治疗子宫动静脉瘘（UAVF）的疗效和安全性。

Three patients completed HIFU treatment in a single session without any major complication. Following HIFU treatment, there was a significant relief in clinical symptoms, particularly abnormal uterine bleeding.

三名患者均在一次治疗中完成了 HIFU 治疗，未出现任何重大并发症。HIFU 治疗后，患者的临床症状显著缓解，尤其是异常子宫出血。

Ultrasound examinations conducted one month after the treatment revealed a notable reduction in the volume of the lesion, ranging from 57% to 100%. Moreover, the efficacy and safety of HIFU treatment remained consistent during the 12-month follow-up period.

治疗后一个月进行的超声检查显示病灶体积显著缩小，缩小幅度为 57% 至 100%。此外，在 12 个月的随访期内，HIFU 治疗的疗效和安全性保持稳定。

HIFU ablation appears to be an effective and safe treatment modality for UAVF. It provides a noninvasive approach with favorable clinical outcomes.

HIFU 消融术是一种有效且安全的 UAVF 治疗方法。它提供了一种无创且具有良好临床疗效的治疗途径。